Cytokinetics, Incorporated Reports Fourth Quarter and Year End Highlights and ... - MarketWatch (press release)
2012-02-02
Cytokinetics, Incorporated Reports Fourth Quarter and Year End Highlights and ...MarketWatch (press release)CK-2017357 was the subject of a key presentation at the 22nd International Symposium on ALS and Motor Neurone Disease and we initiated two additional Phase II multi-dose clinical trials with this novel fast skeletal muscle troponin activator," stated ...and more »
